CHM
Click for more information
5.56% 1.9¢ chimeric therapeutics limited

Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib, page-4

  1. manlymanly
    270 Posts.
    lightbulb Created with Sketch. 209
    clock Created with Sketch.
    24/06/22
    11:33
    Post #: 62183169
    Another trial, great news.. Bio's starting to get some love, they were first to crash so hopefully first to get back to their feet.. I feel we have a bottom now.

    GLTA
    CHM Price at posting: 8.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.9¢ 		Change
0.001(5.56%) 		Mkt cap ! $16.64M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $20.08K 1.065M

Buyers (Bids)

No. Vol. Price($)
9 1573568 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 78200 2
View Market Depth
Last trade - 16.10pm 02/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.